|
Transplant Statistics: Annual Report : Reference Tables
| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | ||
| Transplants | 406 | 535 | 674 | 738 | 893 | 832 | 946 | 891 | 918 | 971 | |
| Tx With Follow-up Immunosuppression Info | 289 | 405 | 530 | 525 | 637 | 568 | 688 | 659 | 645 | 702 | |
| Corticosteroids | Category Usage | 99.7% | 97.8% | 98.9% | 98.1% | 99.1% | 99.3% | 98.4% | 99.5% | 99.7% | 98.9% |
| Prednisone | 99.3% | 97.8% | 98.7% | 98.1% | 99.1% | 98.8% | 98.3% | 99.2% | 99.5% | 98.4% | |
| Methylprednisolone | 2.8% | 0.2% | 2.1% | 0.4% | 1.7% | 1.8% | 1.0% | 3.0% | 2.9% | 4.4% | |
| Cyclosporine | Category Usage | 97.9% | 92.6% | 91.1% | 81.0% | 70.5% | 69.7% | 61.9% | 64.5% | 63.6% | 54.4% |
| Cyclosporin | 97.9% | 91.9% | 90.6% | 71.8% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | |
| Sandimmmune | 0.3% | 0.7% | 2.8% | 8.0% | 35.6% | 14.6% | 8.4% | 6.7% | 4.7% | 3.8% | |
| Neoral | 0.0% | 0.2% | 0.2% | 2.3% | 37.2% | 56.2% | 54.7% | 58.7% | 58.9% | 49.0% | |
| Gengraf | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.2% | 2.7% | |
| Eon | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | 0.1% | |
| Tacrolimus | Category Usage | 2.1% | 6.9% | 9.6% | 11.8% | 23.4% | 33.8% | 37.9% | 41.7% | 47.4% | 56.0% |
| FK506 | 2.1% | 6.9% | 9.6% | 11.8% | 23.4% | 33.8% | 37.9% | 41.7% | 47.4% | 56.0% | |
| Antimetabolites | Category Usage | 98.6% | 96.8% | 97.4% | 95.8% | 89.8% | 88.4% | 88.1% | 92.1% | 91.8% | 94.3% |
| Azathioprine | 98.6% | 96.8% | 97.4% | 94.5% | 79.3% | 68.5% | 57.3% | 62.5% | 58.4% | 53.8% | |
| Mycophenolate mofetil | 0.0% | 0.0% | 0.2% | 1.5% | 12.7% | 23.6% | 33.3% | 37.2% | 40.5% | 48.6% | |
| Other | Category Usage | 0.0% | 0.2% | 0.6% | 0.8% | 0.6% | 0.4% | 0.6% | 0.3% | 6.5% | 6.8% |
| Rapamycin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 6.2% | 6.3% | |
| Cytoxan | 0.0% | 0.2% | 0.6% | 0.8% | 0.6% | 0.4% | 0.6% | 0.2% | 0.3% | 0.7% | |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.